OMB APPROVAL |
OMB Number 3235-0058 |
Expires March 31-2006 |
Estimated average |
Response Hours 2.50 |
SEC File Number 000-30536 |
CUSIP Number |
United States Securities and Exchange Commission
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(check one)
--- Form 10-K
--- Form 20-F
--- Form 11-K
-X- Form 10-Q(SB)
--- Form N-SAR
For Period Ended : September 30, 2005
--- Transition Report on Form 10-K
--- Transition Report on Form 20-F
--- Transition Report on Form 11-K
--- Transition Report on Form 10-Q
--- Transition Report on Form N-SAR
For the Transition Period Ended: -------------------------------------
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.
****************************************************************************************
PART 1 – REGISTRANT INFORMATION
Full Name of Registrant: Total Med, Inc.
Address of Principal Executive Office: 162 M Homestead Street
City, State and Zip Code: Manchester CT 06040
PART II – RULES 12B-25(b) AND (c)
(a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
-X- (b) The subject annual report, semi-annual report, transition
report, on Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion
thereof will be filed on or before the fifteenth calendar
day following the prescribed due date; or the subject
quarterly report on Form 10-Q, or portion there of will be
filed on or before the fifth calendar day following the
prescribed due day; and
(c) The accountant’s statement or other exhibit required by
Rule 12b-25(c) has been attached if applicable.
PART III – NARRATIVE
(State below in reasonable detail why the Form 10-K, 20-F, 11-K, 10-Q, N-SAR, or the
transition report or portion thereof, could not be filed within the prescribed
time period.)
Financial statements have not yet been reviewed. The Company expects to complete the review process within the extension period to allow for timely filing.
PART IV – OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification.
Abraham Pierce (860) 805-0701
------------------ ------------ ---------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of
the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceeding 12 months (or for such
shorter period that the registrant was required to file such reports)
been filed? If the answer is no, identify report(s).
-X- Yes --- No
----------------------------------------------------------------
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report
or portion thereof?
--- Yes -X- No
If so, attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
************************************************************************
SIGNATURE
************************************************************************
Fonecash, Inc.
(Name of Company)
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
By: /s/ Abraham Pierce Date: November 14, 2005
------------------------------------- ------------------------------
Title: President